Update April 3, 2026: Article expanded with Japanese PMDA approval documents: missing studies, S-protein detected in ovaries, post-marketing data from Japan.
There is one critical difference between a conventional mRNA vaccine and what the EU approved in February 2025.
Published September 18, 2025 | Source: Prof. Klaus Steger
In a groundbreaking revelation, official Pfizer approval documents have confirmed what was long dismissed as “conspiracy theory”: The COVID-19 vaccine Comirnaty actually contains SV40 promoter-enhancer sequences and residual DNA packaged together with modRNA in lipid nanoparticles. This disclosure raises fundamental questions about the safety and transparency of a vaccine administered to millions worldwide.
